There’s no doubt about it: Cholesterol drugs have helped save millions of lives. But should these medications be prescribed as preventative medicine for people who do not have cholesterol problems? That’s the question being posed right now as a major drug maker gets ready to market its blockbuster cholesterol-lowering drug to the masses. The marketing campaign comes after the Food and Drug Administration approved the expanded use of AstraZeneca's cholesterol pill Crestor in February. An FDA panel found it can benefit patients with healthy cholesterol levels by preventing heart attack, stroke and death. However, not everyone agrees.
Read full story here.
| < Prev | Next > |
|---|
